Indication

Endometrial Cancer Stage III

1 clinical trial

2 drugs

Clinical trial

A Feasibility Study of Integrated Delivery of Hypofractionated Pelvic IMRT With Carboplatin and Paclitaxel in Stage III Copy-Number Low and Copy-Number High Subtypes of Endometrial Cancer

Status: Recruiting, Estimated PCD: 2025-01-10

Drug

Drug